Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chinese Female Patient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableUnknownNCT04940819
What this trial is testing

A Mobile Application Based Dietary Self Management Intervention in Chinese Chronic Kidney Disease Patients

Who this might be right for
Chronic Renal Disease
Peking Union Medical College Hospital 9,863
Early research (Phase 1)Study completedNCT05861778
What this trial is testing

Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaSuspected Recurrent Renal Clear Cell CarcinomaRecurrent Renal Cell Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 10
Early research (Phase 1)Study completedNCT01152801
What this trial is testing

Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 64
Early research (Phase 1)Looking for participantsNCT04778839
What this trial is testing

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
First Affiliated Hospital of Zhejiang University 98
Not applicableNot Yet RecruitingNCT07657351
What this trial is testing

Effect of Chinese Herbal Medicine on Renal Function in Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
China Medical University Hospital 66
Post-approval studies (Phase 4)Study completedNCT04969627
What this trial is testing

Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.

Who this might be right for
Polycystic Ovary Syndrome
Bing He 60
Large-scale testing (Phase 3)Study completedNCT05067335
What this trial is testing

Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis

Who this might be right for
Osteoporosis
UCB Biopharma SRL 327
Not applicableUnknownNCT01912170
What this trial is testing

Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Gestational Diabetic Patients

Who this might be right for
Gestational Diabetes
Zhejiang University 75
Not applicableStudy completedNCT03433924
What this trial is testing

An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.

Who this might be right for
Urinary Bladder Cancer
AstraZeneca 248
Testing effectiveness (Phase 2)UnknownNCT05641506
What this trial is testing

A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Sichuan Cancer Hospital and Research Institute 50
Large-scale testing (Phase 3)UnknownNCT04842825
What this trial is testing

Sequential Therapy of TCM Herbs to Improve the Success Rate of IVF-ET in Diminished Ovarian Reserve Patients

Who this might be right for
Infertility, Female
Peking University Third Hospital 200
Early research (Phase 1)Study completedNCT02499146
What this trial is testing

Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Pfizer 26
Post-approval studies (Phase 4)UnknownNCT02710747
What this trial is testing

The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.

Who this might be right for
Heart Valve DiseaseOlder Than 18-years-oldWithout Any Liver or Kidney Diseases
Guangdong Provincial People's Hospital 500
Post-approval studies (Phase 4)Study completedNCT04842019
What this trial is testing

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
Kyowa Kirin Co., Ltd. 18